Critical Review: Henry Schein (NASDAQ:HSIC) and Field Trip Health (OTCMKTS:FTRPF)

Henry Schein (NASDAQ:HSIC) and Field Trip Health (OTCMKTS:FTRPF) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Profitability

This table compares Henry Schein and Field Trip Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Field Trip Health	N/A	N/A	N/A

Analyst Ratings

This is a summary of current recommendations and price targets for Henry Schein and Field Trip Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1	5	9	0	2.53
Field Trip Health	0	0	0	0	0.00

Henry Schein presently has a consensus target price of $92.93, suggesting a potential upside of 3.66%. Given Henry Schein’s stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Field Trip Health.

Earnings and Valuation

This table compares Henry Schein and Field Trip Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18 billion	0.76	$398.00 million	$3.43	26.14
Field Trip Health	N/A	N/A	N/A	N/A	N/A

Henry Schein has higher revenue and earnings than Field Trip Health.

Institutional & Insider Ownership

96.6% of Henry Schein shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Henry Schein beats Field Trip Health on 9 of the 9 factors compared between the two stocks.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

About Field Trip Health

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.